Keywords: genentech, halts, pulmozyme, copd, trial, discontinued, its

Genentech Halts Pulmozyme COPD Trial

Article | 17 July 1995

Print This

Genentech has discontinued its Phase III trial of its recombinant DNase product Pulmozyme (dornase alfa) in patients with chronic obstructive ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in